Pharmaceutical industry leaders have called on sales and marketing professionals to place patient safety above profit and to uphold the highest standards of professionalism and scientific integrity. The charge was delivered to members of the Society for Pharmaceutical Sales and Marketing of Nigeria (SPSMN), who were urged to look beyond sales targets and become trusted transformation leaders committed to patients’ health and welfare.
The call came at the 2026 National Pharmaceutical Sales and Marketing Conference of the SPSMN, held in Lagos. With the theme “From Sales Rep to Trusted Transformation Leader: Raising Professional Standards and Capacity in Pharma,” the conference sought to equip sales and marketing professionals with the skills to move beyond traditional sales-driven approaches toward a modern, information-based model that places patients at the centre of pharmaceutical marketing.
The gathering examined the changing responsibilities of pharmaceutical sales representatives at a time of growing concern over counterfeit and substandard medicines, rising operational costs and declining public trust. Stakeholders stressed that patient welfare must remain central to pharmaceutical marketing strategies in order to promote trust, safety and responsible medicine promotion. They also encouraged professionals to embrace technological innovations, including artificial intelligence, to improve efficiency, strengthen stakeholder engagement and raise professional standards.
From Product Dealers to Clinical Educators
In his keynote address, Sola Solarin, Managing Partner of Savante Consulting Limited, said pharmaceutical sales and marketing professionals must embrace fundamental changes to raise professional standards and become transformation leaders. He outlined a series of shifts that define the modern role: moving from product dealer to clinical educator, from pursuing sales targets to transforming health systems, from individual operator to ethical institution builder, and from being controlled by company interests to becoming a strategic champion.
Solarin, a former National Chairman of the Association of Industrial Pharmacists of Nigeria, said pharmaceutical companies should assess sales representatives not only by sales volumes but also by the number of healthcare providers they have trained, the pharmacovigilance reports they have facilitated and the patient education programmes they have supported.
Describing the industry as being in a state of flux, he warned that the changes underway will reshape the landscape for years to come and that only companies that adapt will survive. He urged sales representatives to leverage their market knowledge to help shape their companies’ strategic direction and safeguard their going concern status.
“I want you to remember that you are not just a sales representative carrying a bag; you are a trusted transformation leader carrying the health of a nation and the survival of your company,” Solarin said. He also urged the professionals to shun shortcuts, uphold scientific integrity and strengthen their expertise through conferences and certification programmes. In addition, he advised them to master the diseases their products treat rather than focusing solely on the drugs, and to uphold professional standards and embrace collaboration.
Patient Safety as the Secret of Sales
Ope Oyinola, Managing Director and Chief Executive Officer of Charterhouse Pharmaceutical Limited, who was guest of honour, described sales representatives and marketing professionals as the driving force of pharmaceutical manufacturers and strategic partners in the industry. He urged them to understand the products they promote and to make patient safety their top priority.
“They must see themselves as strategic partners of manufacturers in the industry and as the key note-takers in sales and marketing of pharmaceuticals,” he said. “They should go and learn about the products and put the safety of patients first in everything that they do. They must learn to put patients first. That is the secret of sales. If you put patients first, the issues of quality, sales and profits will be history.”
Oyinola also encouraged the professionals to embrace artificial intelligence to improve efficiency and transform pharmaceutical marketing. “Let us use AI not as an answer, but as a tool to the answer by using it as a tool for efficiency and safety,” he added. He noted that artificial intelligence and other digital technologies could improve efficiency, medicine traceability, inventory management and quality verification.
Caution Against Exaggerated Claims
SPSMN President Tunde Oyeniran cautioned members against unethical practices, exaggerated claims and misinformation that could undermine confidence in individual medicines and in the pharmaceutical industry as a whole. “For us, it’s about knowing your product, knowing your market, and saying exactly what you can do, not one more word,” Oyeniran said.
He explained that the society was established to give pharmaceutical sales and marketing professionals in Nigeria identity, dignity and direction. Describing pharmaceutical sales and marketing as a distinct profession, he noted that the society had set a benchmark for professional conduct in the sector.
Oyeniran identified drug counterfeiting as a major threat to market integrity and consumer safety and called for stronger measures to detect and prevent the circulation of fake medicines. He urged the government to increase funding for regulatory agencies, including the National Agency for Food and Drug Administration and Control (NAFDAC), to strengthen efforts to combat counterfeit medicines.
The SPSMN president also stressed the importance of mentorship, regular professional engagements and strict enforcement of ethical standards. He said the society was working to improve members’ competence and integrity through its code of conduct, adding that professionals must take responsibility for their continuous development.
He urged sales representatives to pursue professional training, adopt ethical practices and make patient safety their overriding priority. He further emphasised the importance of regulatory compliance in the pharmaceutical industry, urging members to ensure that their marketing activities met established professional and legal standards.
A Profession at a Crossroads
The conference underscored a broader shift in how medicines are promoted in Nigeria. As concerns mount over counterfeit and substandard products, rising operational costs and eroding public trust, the traditional image of the sales representative as a bearer of product samples and sales targets is being challenged. In its place, the SPSMN and industry leaders are advocating a model built on scientific knowledge, ethical conduct and measurable contributions to patient care.
For pharmaceutical companies, the message was equally direct: commercial success and patient welfare need not be in conflict. By measuring representatives on the training they deliver, the safety reports they facilitate and the education programmes they support, companies can align their business goals with the health outcomes that matter most to the public. The conference concluded with a clear consensus that the professionals who carry the industry’s products also carry its reputation, and that placing patients first remains the surest path to sustainable growth.